Granules Pharmaceuticals, Inc.
Pharmaceutical ManufacturingVirginia, United States201-500 Employees
Granules Pharmaceuticals, Inc. is a pharmaceuticals company based out of 3701 CONCORDE PKY, Chantilly, Virginia, United States.
Market Positioning Granules Pharmaceuticals operates in the competitive pharmaceutical manufacturing sector with mid-sized revenue, positioning it as an attractive target for suppliers seeking to expand their presence within the United States' pharmaceutical supply chain.
Growth Potential With a revenue range between 100 million and 250 million and a team of up to 500 employees, the company presents opportunities for partnerships in expanding product lines or enhancing manufacturing capabilities.
Technology Adoption Utilizing advanced tech stacks like Google Cloud, Nginx, and PHP suggests a company open to adopting innovative digital solutions, ideal for vendors offering digital transformation or security services.
Industry Collaboration Given its scale and sector, Granules Pharmaceuticals may benefit from collaborations related to supply chain efficiency, compliance solutions, and manufacturing process optimization tailored for pharmaceutical companies.
Competitive Landscape Positioned among similar mid-sized pharma companies, there are opportunities for targeted value propositions focused on cost efficiency, quality assurance, and innovative R&D collaborations to differentiate from larger competitors.
Granules Pharmaceuticals, Inc. uses 8 technology products and services including Sucuri, Google Cloud, PHP, and more. Explore Granules Pharmaceuticals, Inc.'s tech stack below.
| Granules Pharmaceuticals, Inc. Email Formats | Percentage |
| First.Last@granulespharma.com | 98% |
| Last.First@granulespharma.com | 2% |
Pharmaceutical ManufacturingVirginia, United States201-500 Employees
Granules Pharmaceuticals, Inc. is a pharmaceuticals company based out of 3701 CONCORDE PKY, Chantilly, Virginia, United States.
Granules Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M
Granules Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $100M$250M